E. Jassem (Gdansk, Poland), R. Yung (Baltimore Md, United States of America)
Telomerase vs CD34 and MIB1 in non small cell lung cancer
B. Cattaneo, O. Alabiso, D. Colangelo, S. Della Patrona, P. Tarsia, L. Allegra (Milan, Italy)
|   |
Akt induced cytoplasmic mislocalization of p27kip1 protein and correlated with poor prognosis in lung adenocarcinoma
Y. Guo, Y. Xie, X. Wang, H. Yang, M. H. Lee (Guangzhou, China; Texas, United States Of America)
| |
The effects of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro
X. Chen, W. Xiao (Ji Nan, China)
| |
Identification of tumor-associate proteins in stage-I lung squamous cancer by proteomics
X. Zhan, H. Dai, S. Zhang (Beijing, China)
| |
Small cell lung cancer Xenografts can be successfully grafted from bronchoscopy derived samples: model for lung cancer translational research
R. Yung, J. Brandes, K. Romans, C. Rudin, M. Brock (Baltimore, MD, United States Of America)
| |
Low doses of silver nitrate induce pleurodesis with a limited systemic response in rabbits
E. Marchi, F. Vargas, M. Acencio, L. Antonangelo, L. Teixeira, E. Genofre, R. Light (Sao Paulo, Brazil; Nashville, TN, United States Of America)
| |
Diagnostic accuracy of CT-guided coaxial cutting needle lung biopsy of lung nodules
E. Kindt, J. C. Moeller, H. Hansen, F. Lander (Skive, Denmark)
| |
Could 18F-FDG PET repeated within cycle 1 predicts objective response to chemotherapy in advanced non-small cell lung cancer (NSCLC)? A pilot study results
S. Novello, E. Pelosi, M. Giaj Levra, A. Douroukas, M. Longo, E. Capelletto, S. Rapetti, B. Crida, G. Scagliotti (Orbassano, Torino, Italy)
| |
Evaluation of pleural fluid clot histology in the diagnosis of pleural malignancy
S. Direkze, K. Archer, R. Bourkiza, A. Bowzyk, D. Mukherjee, N. Alsanjari (Basildon, Essex, United Kingdom)
| |
The role of PET-CT in mediastinal lymph node staging in NSCLC
S. Erturan, A. Demirkaya, M. Halac, E. Sengul, C. Akman, B. Oz, K. Sonmezoglu, K. Kaynak, G. Aydin, M. Yaman (Istanbul, Turkey)
| |
PET-CT, NSCLC staging and surgery: an audit of current experience
K. Adeniji, A. Banerjee (Hampshire, United Kingdom)
| |
Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung lesions
N. Maounis, A. Lekakou, E. Ellina, D. Melemeni, N. Trakas, M. Chorti, A. Blana, A. Emmanouilidou (Athens, Greece)
| |
Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging?
P. Yildiz, M. Bayraktaroglu, U. Aydogmus, F. Sahin, F. Secik, D. Gorgun, G. Karapinar, M. A. Bedirhan (Istanbul, Turkey)
| |
Two-pore domain K+ channel TASK-1 maintains the membrane potential in non-small cell lung cancer (NSCLC) cells
K. Leithner, C. Wohlkoenig, Y. Li, B. Tang, C. Nagaraj, A. Olschewski, H. Olschewski (Graz, Austria)
| |
Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
O. Chayka, V. Klimenko, A. Barchuk, V. Semiglazov, A. Barchuk (Saint-Petersburg, Russian Federation)
| |
Combined radiation therapy in treatment of tracheal cancers
S. Vucicevic, N. Jovanovic, B. Lukac, D. Grzetic, M. Vidojevic, E. Sudjic (Belgrade, Serbia And Montenegro)
| |
How do lung cancer patients die?
A. Narayanaswamy, M. Thirumaran, K. Lilley, D. Saralaya, B. Jacob (Bradford, United Kingdom)
| |
Detection of lung malignancy using 99mTc/Tektrotyd
T. Adzic, S. Pavlovic, D. Sobic-Saranovic, V. Artiko, V. Obradovic, V. Todorovic-Tirnanic, G. Radosavljevic-Asic, D. Jovanovic, S. Damjanovic (Belgrade, Serbia And Montenegro)
| |
The inhibitory effect of peroxisome proliferator-activated receptor-γ ligands on malignant pleural mesothelioma cell growth
N. Hamaguchi, H. Hamada, M. Okamura, S. Miyoshi, T. Kadowaki, R. Ito, J. Higaki (Ehime, Japan)
| |